Syria's Health Minister signed a five-year memorandum of understanding with U.S. biotechnology company Hematogenix on January 13, 2026, to support the country's healthcare sector in combating cancer, according to QalaatAlMudiq on X reporting over the past 59 minutes between 7:16 PM and 8:15 PM UTC. The agreement aims to strengthen Syria's Cancer Center, advance laboratory diagnostics, and conduct clinical research, as detailed in the QalaatAlMudiq post. In a separate development during the same period, Adm. Brad Cooper, commander of U.S. Central Command, issued a statement, according to the CENTCOM account on X.
